Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study to Compare The Safety and Possible Efficacy of Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis

NCT06466421 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06466421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06466421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study to Compare The Safety and Possible Efficacy of Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis
Lead sponsor
Tanta University
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2024
Completion date
December 20, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease-associated pruritus, end-stage renal disease, esrd, hemodialysis, renal replacement therapy, uremic pruritus